Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2011-2014

ABSTRACT

The purpose of this study is to determine if the investigational drug GTx-024 can help patients with non small cell lung cancer increase physical function and maintain or gain muscle. Detailed Description This is a randomized, double blind, placebo controlled, multicenter, multinational efficacy and safety study in subjects with non small cell lung cancer. Subjects will be evenly randomized to placebo or GTx-024 prior to initiation of first line chemotherapy. The primary efficacy analysis will be based on total Lean Body Mass (LBM) and physical function. More... »

URL

https://clinicaltrials.gov/show/NCT01355497

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The purpose of this study is to determine if the investigational drug GTx-024 can help patients with non small cell lung cancer increase physical function and maintain or gain muscle.\n\nDetailed Description\nThis is a randomized, double blind, placebo controlled, multicenter, multinational efficacy and safety study in subjects with non small cell lung cancer. Subjects will be evenly randomized to placebo or GTx-024 prior to initiation of first line chemotherapy. The primary efficacy analysis will be based on total Lean Body Mass (LBM) and physical function.", 
    "endDate": "2014-06-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01355497", 
    "keywords": [
      "Phase III", 
      "Double-Blind", 
      "Study of the Effect", 
      "muscle wasting", 
      "non small cell lung cancer", 
      "platinum", 
      "investigational drug", 
      "patient", 
      "muscle", 
      "placebo", 
      "multicenter", 
      "efficacy", 
      "safety study", 
      "initiation", 
      "first line chemotherapy", 
      "primary efficacy", 
      "lean", 
      "physical function"
    ], 
    "name": "Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer on First Line Platinum Plus a Non-Taxane Chemotherapy", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01355497"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00010.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.476408.9", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.477270.1", 
        "type": "Organization"
      }
    ], 
    "startDate": "2011-07-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/s11912-016-0522-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017201094", 
          "https://doi.org/10.1007/s11912-016-0522-0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01355497"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01355497'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01355497'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01355497'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01355497'


 

This table displays all metadata directly associated to this object as RDF triples.

43 TRIPLES      16 PREDICATES      35 URIs      27 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01355497 schema:about anzsrc-for:3142
2 schema:description The purpose of this study is to determine if the investigational drug GTx-024 can help patients with non small cell lung cancer increase physical function and maintain or gain muscle. Detailed Description This is a randomized, double blind, placebo controlled, multicenter, multinational efficacy and safety study in subjects with non small cell lung cancer. Subjects will be evenly randomized to placebo or GTx-024 prior to initiation of first line chemotherapy. The primary efficacy analysis will be based on total Lean Body Mass (LBM) and physical function.
3 schema:endDate 2014-06-01T00:00:00Z
4 schema:keywords Double-Blind
5 Phase III
6 Study of the Effect
7 efficacy
8 first line chemotherapy
9 initiation
10 investigational drug
11 lean
12 multicenter
13 muscle
14 muscle wasting
15 non small cell lung cancer
16 patient
17 physical function
18 placebo
19 platinum
20 primary efficacy
21 safety study
22 schema:name Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer on First Line Platinum Plus a Non-Taxane Chemotherapy
23 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01355497
24 schema:sdDatePublished 2019-03-07T15:24
25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
26 schema:sdPublisher N93b79ba0ba444a3c9ec7695b6204f90e
27 schema:sponsor https://www.grid.ac/institutes/grid.476408.9
28 https://www.grid.ac/institutes/grid.477270.1
29 schema:startDate 2011-07-01T00:00:00Z
30 schema:subjectOf sg:pub.10.1007/s11912-016-0522-0
31 schema:url https://clinicaltrials.gov/show/NCT01355497
32 sgo:license sg:explorer/license/
33 sgo:sdDataset clinical_trials
34 rdf:type schema:MedicalStudy
35 N93b79ba0ba444a3c9ec7695b6204f90e schema:name Springer Nature - SN SciGraph project
36 rdf:type schema:Organization
37 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
38 rdf:type schema:DefinedTerm
39 sg:pub.10.1007/s11912-016-0522-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017201094
40 https://doi.org/10.1007/s11912-016-0522-0
41 rdf:type schema:CreativeWork
42 https://www.grid.ac/institutes/grid.476408.9 schema:Organization
43 https://www.grid.ac/institutes/grid.477270.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...